Effects of Pancreas Cold Ischemia on Islet Function and Quality

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1808-1809

  Pileggi, A ^a   Ribeiro, M M ^a   Hogan, A R ^a   Molano, R D ^a   Embury, J E ^b   Ichii, H ^a   Cobianchi, L ^a,c   Fornoni, A ^a   Ricordi, C ^a   Pastori, R L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; COLD ISCHEMIA; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; MALE; NONHUMAN; PANCREAS INJURY; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RAT; TISSUE CULTURE; TISSUE PRESERVATION;

ADENOSINE; ALLOPURINOL; ANIMALS; CELL SURVIVAL; GLUTATHIONE; INSULIN; ISCHEMIA; ISLETS OF LANGERHANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; ORGAN PRESERVATION SOLUTIONS; PANCREAS; PHOSPHOTRANSFERASES; RAFFINOSE; RATS; RATS, INBRED LEW; TISSUE AND ORGAN HARVESTING;

EID: 67249106720     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.03.075     Document Type: Article

References (7)

1. Pileggi A., Cobianchi L., Inverardi L., et al. Overcoming the challenges now limiting islet transplantation: a sequential, integrated approach. Ann N Y Acad Sci 1079 (2006) 383
2. Ponte G.M., Pileggi A., Messinger S., et al. Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors. Cell Transplant 16 (2007) 595
3. Pileggi A., Molano R.D., Ricordi C., et al. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81 (2006) 1318
4. Cobianchi L., Fornoni A., Pileggi A., et al. Riboflavin inhibits IL-6 expression and p38 activation in islet cells. Cell Transplant 17 (2008) 559
5. Ichii H., Inverardi L., Pileggi A., et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 5 (2005) 1635
6. Fornoni A., Pileggi A., Molano R.D., et al. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 51 (2008) 298
7. Pileggi A., Molano R.D., Berney T., et al. Prolonged allogeneic islet graft survival by protoporphyrins. Cell Transplant 14 (2005) 85